Abstract The Japanese Society of Gastroenterology (JSGE) revised the third edition of
evidence-based clinical practice guidelines for peptic ulcer disease in 2020 and created an�…

The sixth edition of the Japanese Gastric Cancer Treatment Guidelines was completed in
July 2021, incorporating new evidence that emerged after publication of the previous�…

Background: Helicobacter pylori eradication treatments are widely performed to improve
gastric mucosal inflammation, promote ulcer healing, and reduce the incidence of gastric�…

Background Potassium‐competitive acid blockers (P‐CAB) are recommended for the
treatment of Helicobacter pylori infections, but dual therapy of P‐CAB with amoxicillin has�…

Objective Helicobacter pylori infection is mostly a family-based infectious disease. To
facilitate its prevention and management, a national consensus meeting was held to review�…

Abstract Background and Aim The efficacy and safety of amoxicillin‐vonoprazan (VA) dual
therapy remained unclear. Methods This systematic review was conducted in accordance�…

Background Vonoprazan‐amoxicillin (VA) dual therapy has been shown to achieve
acceptable cure rates for treatment of Helicobacter pylori (H. pylori) in Japan. Its�…

Infection with Helicobacter pylori is associated with the development of gastric cancer.
Although the prevalence of gastric cancer has declined throughout years due to�…

Background Recent clinical trials have evaluated the efficacy of vonoprazan‐amoxicillin
(VA) dual therapy as the first‐line treatment for Helicobacter pylori infection in different�…

The implementation of primary and secondary preventive strategies is based on the
evidence generated by cancer epidemiology, where the identification of risk factors and the�…